MedPath

Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) Approach

Phase 4
Conditions
Urinary Incontinence, Stress
Registration Number
NCT00135616
Lead Sponsor
Hopital Antoine Beclere
Brief Summary

The purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.

Detailed Description

Urinary stress incontinence (USI) is a frequent pathology in women. Surgical treatment is required in 30 to 50% of women presenting with USI. Several surgical techniques are currently available.

At the present time, the placement of suburethral slings is one of the most efficient techniques. Furthermore, the placement of a suburethral sling is known to be associated with a low rate of complications.

Currently, two approaches are available for the placement of a suburethral sling: retropubic approach (TVT) and trans-obturator approach (TVT-O). The efficacy of these two approaches seem equivalents. However, the morbidity related to these two techniques is probably different. In retrospective studies, the retropubic approach is associated with a higher rate of bladder perforation. On the other hand, the trans-obturator approach is supposed to be associated with a higher rate of post-operative pain.

Thus, the purpose of this study is to compare efficacy and morbidity following the placement of two types of suburethral slings in women presenting with stress urinary incontinence: TVT and TVT-O.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
180
Inclusion Criteria
  • Woman over 18 years old
  • Clinical diagnosis of stress urinary incontinence requiring surgical management
  • Must be able to read and sign the consent
Exclusion Criteria
  • Pregnancy
  • Anti-coagulant treatment
  • Isolated overactive bladder syndrome
  • Genital prolapse requiring surgical treatment
  • Concomitant hysterectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pre operative complication: rate of bladder perforation
post operative complication: rate of post-operative pain
Secondary Outcome Measures
NameTimeMethod
efficacy: disparation of urinary incontinence
safety: sexual behaviour

Trial Locations

Locations (14)

CH Dunkerque

πŸ‡«πŸ‡·

Dunkerque, France

HΓ΄tel Dieu

πŸ‡«πŸ‡·

Clermont-Ferrand, France

Hopital Antoine Beclere

πŸ‡«πŸ‡·

Clamart, France

CH Rouen

πŸ‡«πŸ‡·

Rouen, France

CHU Amiens

πŸ‡«πŸ‡·

Amiens, France

CHU Pellegrin

πŸ‡«πŸ‡·

Bordeaux, France

CH Chambery

πŸ‡«πŸ‡·

Chambery, France

CH Caremeau

πŸ‡«πŸ‡·

Nimes, France

Centre Hospitalier Universitaire

πŸ‡«πŸ‡·

Angers, France

Chu Nancy

πŸ‡«πŸ‡·

Nancy, France

Centre Hospitalier Paul Ardier

πŸ‡«πŸ‡·

Issoire, France

Hopital Saint Andre

πŸ‡«πŸ‡·

Bordeaux, France

CH Rennes

πŸ‡«πŸ‡·

Rennes, France

Hopital Diaconesses Croix Saint Simon

πŸ‡«πŸ‡·

Paris, France

Β© Copyright 2025. All Rights Reserved by MedPath